Citation

Pompili M. Front. Psychiatry 2020; 11: e101.

Affiliation

Department of Neuroscience, Mental Health and Sensory Organs, Suicide Prevention Center, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.

Copyright

(Copyright © 2020, Frontiers Media)

DOI

10.3389/fpsyt.2020.00101

PMID

32180740

PMCID

PMC7057785

Abstract

[This corrects the article DOI: 10.3389/fpsyt.2019.00931.].

Copyright © 2020 Pompili.

A Corrigendum on
Adding Suicide Prevention to the Triple Advantages of Injectable Long-Acting Second-Generation Antipsychotics

By Pompili M. Front. Psychiatry 10:931. doi: 10.3389/fpsyt.2019.00931

The author wishes to disclose that in the last two years he has lectured and served on advisory board honoraria or engaged in clinical trial activities with Angelini, Lundbeck, Janssen, Otsuka, and Allergan.

The author apologizes for this error and states that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Language: en

Keywords

adherence; prevention; relapse; suicide; treatment outcome